Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2000-6-13
pubmed:abstractText
Expression of the cyclin-dependent kinase inhibitor p15(INK4B) frequently is altered in myeloid malignancies. We previously demonstrated that p15(INK4B) is expressed in normal myeloid cells. The aim of this study was to investigate whether p15(INK4B) expression is restricted to the granulomonocytic lineage and to evaluate its modulation during normal and leukemic myeloid differentiation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0301-472X
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
519-26
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:10812241-Antigens, CD34, pubmed-meshheading:10812241-Bone Marrow Cells, pubmed-meshheading:10812241-Carrier Proteins, pubmed-meshheading:10812241-Cell Cycle Proteins, pubmed-meshheading:10812241-Cell Differentiation, pubmed-meshheading:10812241-Cells, Cultured, pubmed-meshheading:10812241-Cyclin-Dependent Kinase Inhibitor p15, pubmed-meshheading:10812241-Cyclin-Dependent Kinase Inhibitor p16, pubmed-meshheading:10812241-Cyclin-Dependent Kinases, pubmed-meshheading:10812241-Gene Expression Regulation, pubmed-meshheading:10812241-Hematopoietic Stem Cells, pubmed-meshheading:10812241-Humans, pubmed-meshheading:10812241-Kinetics, pubmed-meshheading:10812241-Leukemia, pubmed-meshheading:10812241-RNA, Messenger, pubmed-meshheading:10812241-Transcription, Genetic, pubmed-meshheading:10812241-Tretinoin, pubmed-meshheading:10812241-Tumor Suppressor Proteins
pubmed:year
2000
pubmed:articleTitle
Expression of cyclin-dependent kinase inhibitor p15(INK4B) during normal and leukemic myeloid differentiation.
pubmed:affiliation
Departments of Hematology, Catholic University, Rome, Italy. gleone@mware.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't